Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Bonora

Showing results (121-130 of 302) with videos related to

Pageof 31
Sort By:
Clinical Drug Investigation|April 15, 2008
Does iatrogenic scleroderma due to injection-site reaction to enfuvirtide impair absorption of the drug?Paolo Maggi, Raffaele Filotico, Stefano Bonora, et al.
Pharmacogenomics|June 9, 2017
Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokineticsSarah Allegra, Giovanna Fatiguso, Andrea Calcagno, et al.
Antiviral Therapy|January 27, 2018
The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatmentPaolo Bigliano, Andrea Calcagno, Anna Lucchini, et al.
Brain Imaging and Behavior|September 22, 2018
Cerebral white matter Hyperintensities in HIV-positive patientsAlice Trentalange, Adolfo Prochet, Daniele Imperiale, et al.
British Journal of Clinical Pharmacology|September 19, 2002
The unbound percentage of saquinavir and indinavir remains constant throughout the dosing interval in HIV positive subjectsMarta Boffito, Patrick G Hoggard, Helen E Reynolds, et al.
AIDS (London, England)|May 5, 2012
Determinants of darunavir cerebrospinal fluid concentrations: impact of once-daily dosing and pharmacogeneticsAndrea Calcagno, Aylin Yilmaz, Jessica Cusato, et al.
International Journal of Pharmaceutics|December 9, 2015
Ethambutol plasma and intracellular pharmacokinetics: A pharmacogenetic studyGiovanna Fatiguso, Sarah Allegra, Andrea Calcagno, et al.
The Journal of Antimicrobial Chemotherapy|July 6, 2014
Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphismsAntonio D'Avolio, Chiara Carcieri, Jessica Cusato, et al.
International Journal of Clinical Pharmacy|May 16, 2016
Continuous intravenous infusion of enfuvirtide in a patient with a multidrug-resistant HIV strainRobert W Neijzen, Erik M Van Maarseveen, Andy I M Hoepelman, et al.
Travel Medicine and Infectious Disease|March 11, 2022
Trichinella britovi outbreak in Piedmont, North-West Italy, 2019-2020: Clinical and epidemiological insights in the one health perspectiveGiacomo Stroffolini, Luca Rossi, Tommaso Lupia, et al.
Pageof 31

Showing results (121-130 of 302) with videos related to

Sort By:
Pageof 31
Clinical Drug Investigation|April 15, 2008
Does iatrogenic scleroderma due to injection-site reaction to enfuvirtide impair absorption of the drug?Paolo Maggi, Raffaele Filotico, Stefano Bonora, et al.
Pharmacogenomics|June 9, 2017
Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokineticsSarah Allegra, Giovanna Fatiguso, Andrea Calcagno, et al.
Antiviral Therapy|January 27, 2018
The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatmentPaolo Bigliano, Andrea Calcagno, Anna Lucchini, et al.
Brain Imaging and Behavior|September 22, 2018
Cerebral white matter Hyperintensities in HIV-positive patientsAlice Trentalange, Adolfo Prochet, Daniele Imperiale, et al.
British Journal of Clinical Pharmacology|September 19, 2002
The unbound percentage of saquinavir and indinavir remains constant throughout the dosing interval in HIV positive subjectsMarta Boffito, Patrick G Hoggard, Helen E Reynolds, et al.
AIDS (London, England)|May 5, 2012
Determinants of darunavir cerebrospinal fluid concentrations: impact of once-daily dosing and pharmacogeneticsAndrea Calcagno, Aylin Yilmaz, Jessica Cusato, et al.
International Journal of Pharmaceutics|December 9, 2015
Ethambutol plasma and intracellular pharmacokinetics: A pharmacogenetic studyGiovanna Fatiguso, Sarah Allegra, Andrea Calcagno, et al.
The Journal of Antimicrobial Chemotherapy|July 6, 2014
Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphismsAntonio D'Avolio, Chiara Carcieri, Jessica Cusato, et al.
International Journal of Clinical Pharmacy|May 16, 2016
Continuous intravenous infusion of enfuvirtide in a patient with a multidrug-resistant HIV strainRobert W Neijzen, Erik M Van Maarseveen, Andy I M Hoepelman, et al.
Travel Medicine and Infectious Disease|March 11, 2022
Trichinella britovi outbreak in Piedmont, North-West Italy, 2019-2020: Clinical and epidemiological insights in the one health perspectiveGiacomo Stroffolini, Luca Rossi, Tommaso Lupia, et al.
Pageof 31